Literature DB >> 15613692

CTLA-4 blockade: unveiling immune regulation.

Glenn Dranoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15613692     DOI: 10.1200/JCO.2005.09.923

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

Review 1.  Exploiting dendritic cells for active immunotherapy of cancer and chronic infections.

Authors:  David W O'Neill; Nina Bhardwaj
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

2.  Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese.

Authors:  Jie Ge; Lin Zhu; Junde Zhou; Guangxiao Li; Ye Li; Shuying Li; Zhiwei Wu; Jiesheng Rong; Huiping Yuan; Yanhong Liu; Qiang Chi; Daxun Piao; Yashuang Zhao; Binbin Cui
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-22       Impact factor: 4.553

3.  Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfa.

Authors:  Ahmad A Tarhini; Donghoon Shin; Sandra J Lee; Joseph Stuckert; Cindy A Sander; John M Kirkwood
Journal:  Melanoma Res       Date:  2014-04       Impact factor: 3.599

4.  Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.

Authors:  Simon Read; Rebecca Greenwald; Ana Izcue; Nicholas Robinson; Didier Mandelbrot; Loise Francisco; Arlene H Sharpe; Fiona Powrie
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.

Authors:  Mojca Skoberne; Alice Yewdall; Keith S Bahjat; Emmanuelle Godefroy; Peter Lauer; Edward Lemmens; Weiqun Liu; Will Luckett; Meredith Leong; Thomas W Dubensky; Dirk G Brockstedt; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

6.  Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients.

Authors:  Ruggero Ridolfi; Massimiliano Petrini; Laura Fiammenghi; Monica Stefanelli; Laura Ridolfi; Michela Ballardini; Giuseppe Migliori; Angela Riccobon
Journal:  J Transl Med       Date:  2006-08-16       Impact factor: 5.531

7.  Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma.

Authors:  Long Jiang; Shanshan Jiang; Dongrong Situ; Yongbin Lin; Han Yang; Yuanfang Li; Hao Long; Zhiwei Zhou
Journal:  Oncotarget       Date:  2015-04-20

Review 8.  Adjuvant therapy of melanoma with interferon: lessons of the past decade.

Authors:  Paolo A Ascierto; John M Kirkwood
Journal:  J Transl Med       Date:  2008-10-27       Impact factor: 5.531

9.  Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.

Authors:  Lihong Wang; Dalin Li; Zhenkun Fu; Heng Li; Wei Jiang; Dianjun Li
Journal:  BMC Cancer       Date:  2007-09-10       Impact factor: 4.430

Review 10.  Cancer treatment: the combination of vaccination with other therapies.

Authors:  Mads Hald Andersen; Rikke Baek Sørensen; David Schrama; Inge Marie Svane; Jürgen C Becker; Per Thor Straten
Journal:  Cancer Immunol Immunother       Date:  2008-02-20       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.